The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis
- 8 June 2007
- journal article
- review article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 213 (3), 663-671
- https://doi.org/10.1002/jcp.21162
Abstract
The transcriptional coactivator p300 is a ubiquitous nuclear phosphoprotein and transcriptional cofactor with intrinsic acetyltransferase activity. p300 controls the expression of numerous genes in cell‐type and signal‐specific manner, and plays a pivotal role in cellular proliferation, apoptosis, and embryogenesis. By catalyzing acetylation of histones and transcription factors, p300 plays a significant role in epigenetic regulation. Recent evidence suggests that abnormal p300 function is associated with deregulated target gene expression, and is implicated in inflammation, cancer, cardiac hypertrophy, and genetic disorders such as the Rubinstein‐Taybi syndrome. The activity of p300 is regulated at multiple levels, including developmental stage‐specific expression, post‐translational modifications, subcellular localization, and cell‐type and gene‐specific interactions with transcription factors. Although p300 has been investigated extensively in epithelial and hematopoietic cells, its role in fibroblast biology and tissue repair has received little attention to date. Recent studies implicate p300 in the regulation of collagen synthesis by transforming growth factor‐β (TGF‐β). Both the acetyltransferase activity of p300 and its inducible interaction with Smad3 are essential for mediating TGF‐β‐induced stimulation of collagen synthesis. As a signal integrator whose availability for intracellular interactions with transcription factors is strictly limiting, p300 mediates the antagonistic regulation of TGF‐β‐induced collagen synthesis by IFN‐γ and TNF‐α via intracellular competition for limiting amount of p300. Significantly, p300 is itself a direct transcriptional target of TGF‐β in normal fibroblasts, and its levels are significantly elevated in fibrotic lesions as well as in experimental models of fibrosis. The emerging appreciation of the importance of p300 in extracellular matrix (ECM) remodeling and fibrosis and novel insights concerning the regulation, mechanism of action, and significance of p300 in fibroblast biology are discussed in this minireview. J. Cell. Physiol. 213:663–671.Keywords
This publication has 75 references indexed in Scilit:
- Systemic sclerosis: a prototypic multisystem fibrotic disorderJCI Insight, 2007
- Plasmodium falciparum var gene expression is developmentally controlled at the level of RNA polymerase II‐mediated transcription initiationMolecular Microbiology, 2007
- Y-box Protein-1 Is the Crucial Mediator of Antifibrotic Interferon-γ EffectsPublished by Elsevier BV ,2006
- Inhibition of collagen gene expression by interferon‐γ: Novel role of the CCAAT/enhancer binding protein β (C/EBPβ)Journal of Cellular Physiology, 2005
- Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblastsRheumatology, 2005
- Phosphorylation-Dependent Degradation of p300 by Doxorubicin-Activated p38 Mitogen-Activated Protein Kinase in Cardiac CellsMolecular and Cellular Biology, 2005
- Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediatorsBlood, 2004
- Expression of p300 protects cardiac myocytes from apoptosis in vivoBiochemical and Biophysical Research Communications, 2004
- Modulation of Endogenous Smad Expression in Normal Skin Fibroblasts by Transforming Growth Factor-βExperimental Cell Research, 2000
- Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivatorsOncogene, 2000